Access to chemoprevention drugs in the NHS
Centre for Cancer Prevention
Use of medications, such as tamoxifen and aspirin, to reduce the risk of cancer is low among eligible patients. Uptake in chemoprevention trials is higher than initiation rates observed in clinical settings. This project will use data from a large nationally representative survey of 1000 GPs to identify potential barriers to prescribing chemoprevention in the NHS.
Dr Sam Smith
Tel: +44 (0)20 7882 5698